•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Alexandria Marie Lopez of Maison Solutions Inc. Named 2026 LA Executive Awards Nominee
Maison Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer
Notice of Proposed Settlement of Stockholder Derivative Action: Maison Solutions Inc.
Notice of Proposed Settlement of Stockholder Derivative Action: Maison Solutions Inc.
Notice of Proposed Settlement of Stockholder Derivative Action: Maison Solutions Inc.
Maison Solutions Announces Reverse Stock Split
Did Maison Solutions Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Comparing Alto Ingredients (NASDAQ:ALTO) and Maison Solutions (NASDAQ:MSS)
Critical Analysis: Maison Solutions (NASDAQ:MSS) and Advantage Solutions (NASDAQ:ADV)
Maison Solutions Inc. Reports Fiscal 2026 Third Quarter Results
Maison Solutions (MSS) to Release Quarterly Earnings on Monday
Maison Solutions (NASDAQ:MSS) and Chanson International (NASDAQ:CHSN) Critical Analysis
Head-To-Head Survey: Maison Solutions (NASDAQ:MSS) vs. School Specialty (OTCMKTS:SCOO)
Interparfums (NASDAQ:IPAR) versus Maison Solutions (NASDAQ:MSS) Financial Contrast
Reynolds Consumer Products (NASDAQ:REYN) & Maison Solutions (NASDAQ:MSS) Head-To-Head Survey
Maison Solutions (NASDAQ:MSS) and Sow Good (NASDAQ:SOWG) Critical Analysis
Maison Solutions (NASDAQ:MSS) versus HempAmericana (OTCMKTS:HMPQ) Head to Head Analysis